Log in to save to my catalogue

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by ant...

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by ant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e808a7e84bf49808fb4f1b5c809e251

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides

About this item

Full title

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides

Publisher

London, England: SAGE Publications

Journal title

Therapeutic advances in urology, 2011-04, Vol.3 (2), p.51-57

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Background and methods: Antisense oligonucleotides (oligos) have been employed against in vivo and in vitro prostate cancer models targeting growth stimulatory gene products. While most oligos have targeted growth factors or their receptors, others have been directed against inhibitors of apoptosis. In LNCaP cells we evaluated a set of oligos which...

Alternative Titles

Full title

In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4e808a7e84bf49808fb4f1b5c809e251

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e808a7e84bf49808fb4f1b5c809e251

Other Identifiers

ISSN

1756-2872

E-ISSN

1756-2880

DOI

10.1177/1756287211400493

How to access this item